Takeda inks a $270M stem cell deal with Kyoto University – FierceBiotech
News-Medical.net |
Takeda inks a $270M stem cell deal with Kyoto University
FierceBiotech Takeda has struck up a 10-year partnership with Japan’s Kyoto University to develop potential stem cell treatments for an array of diseases, committing about $270 million to the effort. Under the agreement, Takeda and the school’s Center for iPS Cell … Takeda, CiRA Launch $268.5M iPS CollaborationGenetic Engineering & Biotechnology News (blog) CiRA, Takeda collaborate to develop clinical applications of iPS cellsNews-Medical.net CiRA, Takeda to develop iPS cell applicationsPharmaceutical Business Review |
News-Medical.net |
Takeda inks a $270M stem cell deal with Kyoto University
FierceBiotech Takeda has struck up a 10-year partnership with Japan’s Kyoto University to develop potential stem cell treatments for an array of diseases, committing about $270 million to the effort. Under the agreement, Takeda and the school’s Center for iPS Cell … Takeda, CiRA Launch $268.5M iPS CollaborationGenetic Engineering & Biotechnology News (blog) CiRA, Takeda collaborate to develop clinical applications of iPS cellsNews-Medical.net CiRA, Takeda to develop iPS cell applicationsPharmaceutical Business Review |
Genetic Engineering & Biotechnology News |
Newly Found Stem Cell State Closer to Transitional Precipice
Genetic Engineering & Biotechnology News Embryonic lineages may emerge from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), which are generally considered pluripotent, not totipotent, because they have not been thought capable of giving rise to extraembryonic cell … |
|
ReNeuron stem cell therapy shows long-term promise for stroke
Reuters The procedure involves injecting ReNeuron’s neural stem cells into patients’ brains to repair areas damaged by stroke, thereby improving both mental and physical function. The Phase I trial is designed primarily to test whether the experimental … |
|
ReNeuron stem cell therapy shows long-term promise for stroke
Reuters The procedure involves injecting ReNeuron’s neural stem cells into patients’ brains to repair areas damaged by stroke, thereby improving both mental and physical function. The Phase I trial is designed primarily to test whether the experimental … |
|
Stem cell research proves beneficial and controversial
KTAL It’s a debate that puts many people’s religious beliefs at odds with science. Medical breakthroughs have allowed doctors to use human stem cells to treat chronic diseases with incredible results, but even patients who benefit have reservations about … |